FDA.reportPublic FDA data

Ubrelvy 100 MG Oral Tablet

RxCUI
2268227
RxNorm name
Ubrelvy 100 MG Oral Tablet
Display name
Ubrelvy 100 MG Oral Tablet
Full name
Ubrelvy 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UBRELVYUBROGEPANTAllergan, Inc.fd9f9458-fd96-4688-be3f-f77b3d1af6ab2025-06-05Warnings, Adverse reactionsExact identifier
rxcui: 2268227

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fd9f9458-fd96-4688-be3f-f77b3d1af6abubrelvy 100 MG Oral Tablet [PSN] · ubrogepant 100 MG Oral Tablet [Ubrelvy] [SBD] · Ubrelvy 100 MG Oral Tablet [SY]327These highlights do not include all the information needed to use UBRELVY safely and effectively. See full prescribing information for UBRELVY. UBRELVY ® (ubrogepant) tablets, for oral use Initial U.S. Approval: 201920250605